From Yahoo Finance: 2025-05-11 16:59:00

In a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies, Novo Nordisk A/S (NYSE:NVO) stands out. Jim Simons, known as the “Quant King,” founded Renaissance Technologies, a quantitative trading firm, leading to impressive returns through data-driven investment strategies. The secretive Medallion hedge fund within Renaissance has consistently outperformed, with annual returns of 31.5%.

Renaissance Technologies has seen continued success in 2024, with its Institutional Diversified Alpha Fund gaining 9.05% and the Institutional Equities Fund rising 11.85%. These funds utilize individual stock positions, stock index futures, and options to manage risk. Top stock picks from the firm’s 13F portfolio are popular among elite hedge funds.

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company known for treating rare diseases, diabetes, and obesity. Despite BofA Securities lowering its price target, the company remains confident in a second-half year inflection. Novo Nordisk expects growth from initiatives and a focused commercial strategy, emphasizing the benefits of Wegovy and Ozempic.

NVO ranks 3rd on the list of best stocks recommended by Jim Simons’ Renaissance Technologies. While NVO shows promise as an investment, the potential for higher returns in a shorter time frame may lie in AI stocks. Consider exploring AI stocks for significant gains, as some have outperformed popular options in 2025.

Read more: Is Novo Nordisk (NVO) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?